Highlights

Novavax's vaccine gets approved for children
Novavax: vaccine was 80% effective against Covid-19
In India, Covovax is manufactured by Serum Institute of India.

Latest news

Asus Pad T3201 Review: OLED Brilliance Meets Everyday Mid-Range Power

Qualcomm Showcases Snapdragon 8 Elite Gen 6 Chips At IMC 2026, Teases New Flagships

Shokz Diwali Sale Brings Discounts On Open-Ear Headphones Across Amazon And Flipkart

iQOO 16 Confirmed For India With Snapdragon 8 Elite Extreme Gen 6 And OriginOS 7

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Emotion, tears as Messi retires from Argentina national team

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

Covovax gets emergency use approval for children aged 12-17 in India

Name: Covovax gets emergency use approval for children aged 12-17 in India
Uploaded: 2022-03-23T09:43:22.000+05:30
Duration: T01M00S
Channel: Editorji News Desk
Description: American biotechnology company Novavax has said that its Covid-19 vaccine has got emergency use authorisation for children in 12-17 years age group by India's drug regulator. The company has clained that its vaccine produced ...

Covovax is the fourth Covid-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

Updated: Sep 02, 2022 10:53

Editorji News Desk

Join our WhatsApp Channel

Covovax gets emergency use approval for children aged 12-17 in India

American biotechnology company Novavax has said that its Covid-19 vaccine has got emergency use authorisation for children in 12-17 years age group by India's drug regulator.

The company has claimed that its vaccine produced an immune response in the same age group in a mid- to late-stage study involving 460 Indian adolescents.

Last month Novavax had said its vaccine was 80% effective against Covid-19 in a late-stage trial testing the shot in 2,247 children aged 12 to 17 years.

The vaccine is manufactured in India by Serum Institute of India under the name of Covovax

Also watch: Covovax Explained: Adding another weapon to India's Covid arsenal

Covovax is the fourth Covid-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

Frequently Asked Questions

What is Covovax?❯

Covovax is the brand name for Novavax's Covid-19 vaccine manufactured in India by Serum Institute of India.

For which age group did Novavax get emergency use approval in India?❯

How effective is Covovax against Covid-19?❯

Which other vaccines are approved for adolescents in India?❯

Which company manufactured Covovax?❯

Up Next

Covovax gets emergency use approval for children aged 12-17 in India

Union minister says India's Covid vaccine programme more advanced than USA's

Covid-19: minor drop in cases, deaths across India in 24 hours

Covid: India's daily new infections, active cases decline

Covid: India's active cases decline after nearly 70 days

Covid 19: India records 12,193 cases in last 24 hours

Highlights

Latest news

Covovax gets emergency use approval for children aged 12-17 in India

Frequently Asked Questions

Up Next

More videos

Categories